Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
German defence group Rheinmetall is considering acquiring the bankrupt shipyard in Mangalia, in partnership with Swiss shipping company MSC. The potential takeover could transform the facility into a dual-use hub for military and civilian shipbuilding.
Romania ranks first in the European Union for the real burden of electricity prices, with a nominal value 21% above the European average, according to an analysis published by the Intelligent Energy Association (AEI).
The Romanian leu depreciated on Tuesday against the euro, which was calculated by the National Bank of Romania (BNR) at RON 5.2180 lei, up 0.35%, recording a new historic high.
Romania's Ministry of Finance will launch the fifth edition of its Fidelis government bond programme from 8-15 May 2026, offering tax-free yields of up to 7.50% for lei-denominated bonds and up to 6.25% for euro-denominated issues.
The Romanian leu depreciated on Wednesday against the euro, which was calculated by the National Bank of Romania (BNR) at RON 5.2688, up 0.97% from the previous rate, recording a new historic high.